EAM Investors’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-140,850
Closed -$1.85M 323
2019
Q2
$1.85M Buy
140,850
+46,468
+49% +$610K 0.45% 78
2019
Q1
$898K Buy
+94,382
New +$898K 0.22% 196